| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/26/2001 | US6251436 Drug preparations for treating sexual dysfunction |
| 06/24/2001 | CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 06/21/2001 | WO2001044502A2 Genetic variants of the human fsh receptor and the influence thereof on gametogenesis |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 06/21/2001 | WO2001044267A1 11-β-PHENYLESTRADIENE DERIVATIVES WITH FLUOROALKYL GROUPS IN THE AROMATIC SIDE CHAIN, PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
| 06/21/2001 | WO2001044246A1 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | WO2001044228A2 Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses |
| 06/21/2001 | WO2001044227A1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 06/21/2001 | WO2001044207A2 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 06/21/2001 | WO2001044206A1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001043763A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | WO2001043748A2 Implant composition containing melengestrol acetate and trenbolone acetate |
| 06/21/2001 | WO2001043744A1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 06/21/2001 | WO2001043720A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | WO2001043540A2 Methods for producing transgenic animals |
| 06/21/2001 | WO2000039095B1 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 06/21/2001 | DE19959697A1 14,15-Cyclopropanosteroide der 19-Norandrostan-Reihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 14,15-Cyclopropanosteroide the 19-norandrostane series, process for their preparation and pharmaceutical compositions containing them |
| 06/21/2001 | DE19959696A1 Ungesättigte 14,15-Cyclopropano-Androstane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Unsaturated 14,15-cyclopropano-androstanes, to processes for their preparation containing these compounds and pharmaceutical compositions |
| 06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | CA2394600A1 Methods for producing transgenic animals |
| 06/21/2001 | CA2394576A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2394416A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | CA2394160A1 Human oxidoreductase proteins |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2391950A1 Implant composition containing melengestrol acetate and trenbolone acetate |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/21/2001 | CA2363100A1 Genetic variants of the human fsh receptor and the influence thereof on gametogenesis |
| 06/20/2001 | EP1108426A2 Use of prostaglandin agonists to treat erectile dysfunction or impotence |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108024A1 Lim domain protein homolog |
| 06/20/2001 | EP1107971A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 06/20/2001 | EP1107968A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107775A1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 06/20/2001 | EP1107762A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 06/20/2001 | EP1107759A1 Pyridinones for the treatment of sexual dysfunction |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107746A2 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 06/20/2001 | EP0934301B1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors |
| 06/20/2001 | EP0686037B1 Hormone replacement therapy |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1300219A Epiallopregnanolone in the treatment of CNS disorders |
| 06/20/2001 | CN1300218A Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 06/20/2001 | CN1299678A Chinese medicine shennongjingguling |
| 06/20/2001 | CN1067384C Adhesion receptor antagonists, its preparation method and use as farm chemicals |
| 06/20/2001 | CN1067261C Lactation promoting health care oral liquid for paturient |
| 06/19/2001 | US6248907 Alpha 1 and alpha 2 adrenoceptor antagonistic effects and urogenital selectivity; benign prostate hyperplasia; dibenzoyltartrate salt |
| 06/19/2001 | US6248786 Sexual disorders |
| 06/19/2001 | US6248783 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | US6248747 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 06/19/2001 | US6248738 Isoquinolines as urokinase inhibitors |
| 06/19/2001 | US6248557 RatC |
| 06/19/2001 | US6248368 Administering magnesium salt |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248358 Bioadhesive progressive hydration tablets and methods of making and using the same |
| 06/19/2001 | US6248335 Ph control |
| 06/19/2001 | US6248305 Boron heterocycle steroid mimics and associated pharmaceutical compositions and methods of use |
| 06/19/2001 | CA2218616C Nitrosylated neuropeptides |
| 06/19/2001 | CA2013893C Tetrahydrobenz¬c,d|indole serotonin agonists |
| 06/19/2001 | CA1341260C Pharmaceutical and/or dietary compsitions containing l-carnitine and l- lysine |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042275A1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 06/14/2001 | WO2001042274A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 06/14/2001 | WO2001042244A1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/14/2001 | WO2001041809A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 06/14/2001 | WO2001041807A2 Transmucosal composition containing a phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041704A2 Method for the prevention and/or treatment of atherosclerosis |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001027101A3 Anhydrous salt |
| 06/14/2001 | WO2001019354A3 Composition for ivf |
| 06/14/2001 | WO2001018040A3 Use of leptin in inhibition of endothelial cell proliferation |
| 06/14/2001 | WO2001017989A3 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists |
| 06/14/2001 | WO2001016133A3 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 06/14/2001 | WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 06/14/2001 | WO2001000829A8 Human endogenous retrovirus in breast cancer |
| 06/14/2001 | WO2001000812A3 22012, a novel human carboxypeptidase |
| 06/14/2001 | US20010003749 Arylpiperazines having activity at the serotonin 1A receptor |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2394060A1 Transmucosal administration of phosphodiesterase inhibitor for the treatment of erectile dysfunction |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |